New Edge Wealth, LLC Astrazeneca PLC Transaction History
New Edge Wealth, LLC
- $5.35 Billion
- Q1 2025
A detailed history of New Edge Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, New Edge Wealth, LLC holds 38,617 shares of AZN stock, worth $2.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
38,617
Previous 37,190
3.84%
Holding current value
$2.7 Million
Previous $2.44 Million
16.5%
% of portfolio
0.05%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.99 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.84 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.49 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.23 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.19 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $217B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...